Nike is expected to post its steepest revenue decline in nearly five years in its quarterly results on Thursday, as its new products failed to open the wallets of Americans reluctant to snap up non-essential items like sporting goods and clothing.

Amazon.com Inc. NASDAQ: AMZN stock is currently down about 20% from its all-time high in February, placing it in bear market territory. While some of this decline is tied to the broader market's downturn, the drop seems increasingly irrational given the company's record-breaking earnings and continued long-term growth.

SYKESVILLE, Md.--(BUSINESS WIRE)--Coronis Health, (Coronis) a leading provider of healthcare revenue cycle management (RCM) solutions, is pleased to announce that it has leveraged the UiPath Platform™ to enhance its healthcare delivery systems. As part of its comprehensive digital transformation strategy, Coronis leverages the UiPath Platform to enhance advanced AI capabilities while ensuring transparency, security, compliance and ethical governance in all automated processes, driving significa.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In e.l.f. Beauty To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Neumora To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Neumora pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Offering Documents") issued in connection with Neumora's September 2023 initial public offering (the "IPO") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Faruqi & Faruqi, LLP, a leading national …

Jack in the Box's targeted marketing campaigns, digital enhancements and franchise expansion plan propel it for growth.

NVS reports new safety and efficacy data from the phase III program for its investigational OAV101 IT gene therapy for SMA patients.

PRA shareholders will receive $25 per share in cash from the $1.3 billion acquisition by The Doctors Company.

Academy Sports and Outdoors, Inc. (ASO) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $2.21 per share a year ago.

FinWise Bancorp (FINW) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Duluth Holdings (DLTH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Corbus Pharmaceuticals (CRBP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

The heavy selling pressure might have exhausted for Nkarta (NKTX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

'Reference customers loved Akamai's detection capabilities and appreciated how easy it is to automate functionality.' CAMBRIDGE, Mass.

Accenture PLC (NYSE:ACN) and Five Below Inc (NASDAQ:FIVE) stocks are making significant moves following their latest earnings reports.

Candel Therapeutics Inc (NASDAQ:CADL) announced that it has partnered with IDEA Pharma to advance the commercialization of its lead immunotherapy candidate CAN-2409. The collaboration follows positive Phase 3 data showing CAN-2409 significantly improved disease-free survival in patients with intermediate-to-high-risk localized prostate cancer.

The U.S. cannabis industry continues expanding, creating opportunities for ancillary companies that support cultivation and retail operations the U.S. legal cannabis industry experienced significant growth, with sales reaching approximately $31.4 billion, marking a 9.14% increase from the previous year. Industry experts predict sales could reach $50 billion by 2028 as more states legalize marijuana. Recently, Congress discussed federal cannabis reform, increasing speculation about potential rescheduling. If federal legalization advances, ancillary stocks could see strong momentum. These companies provide essential products, including hydroponics, lighting, and packaging, benefiting from growing cannabis demand. As the industry evolves, investors are closely watching top-performing ancillary …

Denali (DNLI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

CVX CEO Mike Wirth lobbies Washington for a 60-day extension to wind down operations in Venezuela after Trump revokes its oil pumping license.

Jabil (JBL) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.81 per share. This compares to earnings of $1.68 per share a year ago.